M. Roy

Role of Cytochrome P450 Isoenzymes 3A and 2D6 in the In Vivo Metabolism of Mirabegron, a β3-Adrenoceptor Agonist

D. Kowalski, J. Keirns, W. Krauwinkel, 2013, Clinical Drug Investigation.

Population Pharmacokinetics of Micafungin in Neonates and Young Infants

P. Smith, D. Benjamin, M. Cohen-Wolkowiez, 2010, Antimicrobial Agents and Chemotherapy.

Population Pharmacokinetics of Micafungin and Its Metabolites M1 and M5 in Children and Adolescents

D. Benjamin, W. Hope, A. Arrieta, 2014, Antimicrobial Agents and Chemotherapy.

Pharmacokinetic and Safety Profiles of Repeated-dose Prophylactic Micafungin in Children and Adolescents Undergoing Hematopoietic Stem Cell Transplantation

A. Arrieta, N. Azie, R. Townsend, 2015, Journal of pediatric hematology/oncology.

Safety and Pharmacokinetic Profiles of Repeated-dose Micafungin in Children and Adolescents Treated for Invasive Candidiasis

D. Benjamin, A. Arrieta, J. Deville, 2013, The Pediatric infectious disease journal.

Guidelines for the Quality Control of Population Pharmacokinetic–Pharmacodynamic Analyses: an Industry Perspective

P. Bonate, S. Tannenbaum, A. Yassen, 2012, The AAPS Journal.